Quarterly turnover from adrenergic receptor agonists in Denmark 2018
This statistic shows the quarterly turnover from adrenergic receptor agonists, used to treat respiratory and pulmonary disease, in Denmark in 2018. The highest turnover during 2018 was in the second quarter, which amounted to 193.3 million Danish kroner.